Lab Automation Solutions (Pre-Analytical) Market Global Report 2026

The lab automation solutions (pre-analytical) market size has grown strongly in recent years. It will grow from $2.58 billion in 2025 to $2.81 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing laboratory workload due to rising diagnostic testing volumes, growing need to reduce manual sample processing errors, rising focus on laboratory staff safety and biohazard protection, increasing demand for faster diagnostic turnaround times, growing adoption of laboratory workflow standardization practices.

The lab automation solutions (pre-analytical) market size is expected to see strong growth in the next few years. It will grow to $3.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing integration of intelligent automation in clinical laboratories, growing demand for high-throughput diagnostic processing, rising adoption of connected laboratory ecosystems, increasing need for efficient sample traceability solutions, expanding deployment of automated diagnostics infrastructure. Major trends in the forecast period include increasing adoption of robotic specimen handling systems for automated laboratory workflows, growing demand for integrated pre-analytical automation solutions to reduce laboratory turnaround time, rising deployment of automated sample sorting and routing systems for improved processing efficiency, increasing preference for modular laboratory automation systems to support scalable operations, growing adoption of automated barcode identification and tracking systems for specimen traceability.

The increasing volume of diagnostic testing is expected to drive the growth of the lab automation solutions (pre-analytical) market going forward. Diagnostic testing refers to the process of analyzing patient samples to identify, confirm, monitor, or exclude diseases and medical conditions through laboratory examination. The volume of diagnostic testing is increasing as healthcare providers expand disease screening programs, early detection initiatives, and routine health monitoring to improve patient outcomes. Lab automation solutions (pre-analytical) address the growing demand for diagnostic testing by automating specimen identification, sorting, preparation, and movement processes, allowing laboratories to handle higher sample volumes with improved speed, accuracy, and traceability. For instance, in October 2025, according to the National Health Service (NHS), a UK-based publicly funded healthcare system, record levels of diagnostic activity were achieved during 2024/25, with an average of 2.4 million diagnostic tests performed per month, representing an 8% increase compared with the previous year. Therefore, the increasing volume of diagnostic testing is driving the growth of the lab automation solutions (pre-analytical) market.

Leading companies operating in the lab automation solutions (pre-analytical) market are concentrating on developing advanced solutions, such as total lab automation systems, to improve specimen handling efficiency, enhance workflow integration, reduce manual intervention, and increase laboratory productivity. A total lab automation system is an integrated solution that automates laboratory processes, including sample handling, testing, data management, and result reporting, to improve efficiency, accuracy, and throughput. For example, in July 2024, Inpeco SA, a Switzerland-based medical technology company, launched FlexLab X, its next-generation total laboratory automation system, at the ADLM 2024 Clinical Lab Expo. The platform features modular automation, intelligent specimen routing, integrated pre-analytical processing, full sample traceability, open connectivity with analyzers from multiple vendors, and advanced workflow management through DMX software, enabling clinical laboratories to improve operational efficiency, standardize specimen processing, and optimize laboratory workflows.

In January 2025, Merck & Co. Inc., a US-based global pharmaceutical and biopharmaceutical company, partnered with Opentrons Labworks Inc. to automate assay kit processes. Through this partnership, the companies aimed to advance laboratory automation by combining automated liquid handling technologies with workflow management solutions, improving pre-analytical sample preparation, enhancing laboratory productivity, and enabling scalable and consistent research and diagnostic processes. Opentrons Labworks Inc. is a US-based laboratory automation company that develops automated liquid handling robots, laboratory automation platforms, and sample preparation technologies.

Major companies operating in the lab automation solutions (pre-analytical) market report are Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Inpeco SA, Tecan Group, Hamilton Company, Thermo Fisher Scientific, Sysmex Corporation, BD (Becton Dickinson and Company), Copan Diagnostics, Mitsubishi Electric Corporation, HORIBA Ltd., FANUC Corporation, Yaskawa Electric Corporation, Epson Robots, Omron Corporation, Automata Technologies, Kawasaki Heavy Industries, Brooks Automation (Azenta), Greiner Bio-One International, Fraunhofer IPA, LiCONiC AG, BioNex Solutions, Aurora Biomed, Festo AG.

North America was the dominant region in the lab automation solutions (pre-analytical) market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the lab automation solutions (pre-analytical) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation solutions (pre-analytical) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.